Delivery Order SPE2DB20D3101-SPE2DB25FQUR0

Award Date 11/13/24
Potential Completion Date 11/14/24
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $40,209.52 Firm Fixed Price delivery order contract is for the provision of Telmisartan 40 mg tablets to support federal healthcare programs. The contract has an ultimate completion date of September 27, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $1,323.50, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of Telmisartan 40 mg tablets. The contract has an ultimate completion date of February 19, 2025 and is a firm fixed-price delivery order. The award is not designated as a set-aside contract. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $3,547.16, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Telmisartan 40 mg tablets. It is a firm-fixed-price delivery order contract with a completion date of June 6, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of 4,563,699,383 units of telmisartan 40 mg tablets. The $3,227.80 firm fixed-price delivery order contract has a completion date of February 20, 2024 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,249.00 Firm Fixed Price Delivery Order is for the supply of Telmisartan 40 mg tablets, a medication used to treat high blood pressure. The contract has an ultimate completion date of March 20, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award is a Delivery Order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Telmisartan 40 mg tablets. The firm-fixed-price contract has a ceiling value of $2,421.60 and an ultimate completion date of November 21, 2023. The contract is not designated as a set-aside and represents a standard competitive award. AmerisourceBergen, a major pharmaceutical distributor, has established an Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,140.36, is for the delivery of Telmisartan 40 mg tablets in 30-count packages. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,336.61, is for the delivery of Telmisartan 40 mg tablets. It is a firm-fixed-price delivery order contract with a completion date of February 8, 2024. The contract is not designated under any set-aside program. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Telmisartan 40 mg tablets. The contract has a firm-fixed price of $1,355.12 and an ultimate completion date of August 21, 2024. AmerisourceBergen has been awarded this delivery order as part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which enables...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a Delivery Order valued at $1,751.57 for the delivery of Telmisartan 40 mg tablets. The contract has a period of performance through November 28, 2023 and is a Firm Fixed Price arrangement. AmerisourceBergen has established Indefinite Delivery Contracts (IDCs) with both the DLA Troop Support Medical and the...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB25FQUR0
    Delivery Order

This federal contract award, valued at $1,369.92, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of telmisartan 40 mg tablets. The contract is a Firm Fixed Price Delivery Order, with a completion date of November 14, 2024. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that holds multiple Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice Federal Bureau of Investigation, valued at $999,999,999 and $750,000 respectively, for the provision of a comprehensive range of pharmaceutical products and medical supplies to support federal healthcare programs, including those serving military personnel and veterans.

Generated 5/20/25, 2:19 PM